Centre Antoine Lacassagne
Clinical trials sponsored by Centre Antoine Lacassagne, explained in plain language.
-
New combo therapy shows promise for lymphoma in seniors
Disease control CompletedThis study tested a two-step treatment for adults aged 65 to 80 with a type of lymphoma. First, they received standard chemotherapy plus a targeted antibody (rituximab). Then, they got more rituximab and a radioactive antibody (Y90 ibritumomab) to kill remaining cancer cells. The…
Phase: PHASE2 • Sponsor: Centre Antoine Lacassagne • Aim: Disease control
Last updated May 26, 2026 09:02 UTC
-
Can special nutrition cut infection risk after cancer surgery?
Disease control CompletedThis study tested three different nutrition plans given through a feeding tube to see which one best prevents infections after surgery for head and neck cancer. 311 patients took part. The goal was to find the most effective way to support recovery and reduce complications.
Phase: PHASE3 • Sponsor: Centre Antoine Lacassagne • Aim: Disease control
Last updated May 26, 2026 09:01 UTC
-
New drug cocktail shows promise for tough pancreatic cancer
Disease control CompletedThis early-phase study tested a combination of three drugs (gemcitabine, capecitabine, and erlotinib) in 30 people with advanced pancreatic cancer that had already been treated. The main goal was to find the safest dose and understand side effects. This is not a cure, but aims to…
Phase: PHASE1 • Sponsor: Centre Antoine Lacassagne • Aim: Disease control
Last updated May 26, 2026 08:56 UTC
-
Precision radiation boost after chemo shows promise for tough lung cancers
Disease control CompletedThis study looked at giving a precise, high-dose radiation treatment called CyberKnife after standard chemotherapy and radiation for people with stage III non-small cell lung cancer that could not be removed with surgery. The goal was to find the safest highest dose of CyberKnife…
Phase: NA • Sponsor: Centre Antoine Lacassagne • Aim: Disease control
Last updated May 26, 2026 08:55 UTC
-
One-Time radiation blast shows promise for prostate cancer
Disease control CompletedThis study tested a single, high-dose radiation treatment for men with low-risk prostate cancer. The goal was to see how well the body tolerates this one-time procedure by tracking side effects in the urinary and digestive systems for 6 months. 35 men participated, and the treatm…
Phase: NA • Sponsor: Centre Antoine Lacassagne • Aim: Disease control
Last updated May 26, 2026 08:32 UTC
-
New combo therapy for breast cancer shows promise in early trial
Disease control CompletedThis early-phase study tested a new approach for women with breast cancer who cannot have breast-conserving surgery. It combined a short course of high-dose radiation (Cyberknife) with standard chemotherapy drugs. The main goal was to find the safest radiation dose and see how we…
Phase: PHASE1 • Sponsor: Centre Antoine Lacassagne • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
New radiation method during surgery shows promise for early breast cancer
Disease control CompletedThis study tested a new way to give radiation therapy during breast cancer surgery, called intraoperative radiotherapy. It included 28 women aged 60 or older with early-stage, low-risk breast cancer. The goal was to see if the technique could deliver the right dose of radiation t…
Phase: NA • Sponsor: Centre Antoine Lacassagne • Aim: Disease control
Last updated May 18, 2026 12:01 UTC
-
One-and-Done radiation boost shows promise for breast cancer patients
Disease control CompletedThis study tested a new way to give an extra dose of radiation (a boost) to the tumor site after standard breast radiation. Instead of multiple sessions, the CyberKnife machine delivered a single high dose very precisely, aiming to reduce skin damage and improve cosmetic results.…
Phase: NA • Sponsor: Centre Antoine Lacassagne • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
Triple therapy shows promise for aggressive head and neck cancers
Disease control CompletedThis study tested a combination of chemotherapy, radiation, and a targeted drug called cetuximab in 53 patients with head and neck cancer who had a high risk of the cancer coming back after surgery. The goal was to see if this triple therapy could keep the cancer from returning f…
Phase: PHASE2 • Sponsor: Centre Antoine Lacassagne • Aim: Disease control
Last updated May 14, 2026 12:01 UTC
-
New brain scan clears up tumor confusion, speeds treatment decisions
Diagnosis CompletedThis study tested whether a special PET scan called 18F-FDOPA can help doctors make better treatment decisions for people with brain tumors (gliomas or metastases) when standard MRI results are unclear. 85 patients whose MRI scans left doctors unsure about the next step received …
Phase: NA • Sponsor: Centre Antoine Lacassagne • Aim: Diagnosis
Last updated May 26, 2026 09:01 UTC
-
Can MRI better measure early breast cancer?
Diagnosis CompletedThis study looked at how well MRI scans can measure the size of ductal carcinoma in situ (DCIS), a very early form of breast cancer. Forty women with DCIS had an MRI before surgery, and the MRI results were compared to the actual tumor size found during surgery. The goal was to s…
Phase: NA • Sponsor: Centre Antoine Lacassagne • Aim: Diagnosis
Last updated May 18, 2026 12:10 UTC
-
New PET scan trick may spot fake tumor growth in immunotherapy patients
Diagnosis CompletedThis study looked at 100 people with advanced lung cancer or melanoma who were getting immunotherapy. Researchers used a special PET scan to see if they could tell the difference between real tumor growth and inflammation that looks like growth. The goal was to improve how doctor…
Phase: NA • Sponsor: Centre Antoine Lacassagne • Aim: Diagnosis
Last updated May 04, 2026 16:19 UTC
-
Seed vs wire: which tumor marker works best for breast surgery?
Symptom relief CompletedThis study tested two ways to mark non-palpable breast tumors before surgery: a tiny iodine seed versus a standard metal wire. 350 women with early breast cancer took part. The goal was to see if the seed method leads to cleaner surgical margins and less pain. Results help doctor…
Phase: NA • Sponsor: Centre Antoine Lacassagne • Aim: Symptom relief
Last updated May 26, 2026 09:04 UTC
-
Phone Check-Ins ease chemo side effects, study finds
Symptom relief CompletedThis study looked at whether two phone calls during the first three rounds of chemotherapy could improve the emotional well-being of patients with breast or colon cancer. 274 patients were randomly assigned to receive either standard care or additional phone support. The goal was…
Phase: NA • Sponsor: Centre Antoine Lacassagne • Aim: Symptom relief
Last updated May 26, 2026 08:58 UTC
-
Brain tumor scan could change treatment plans in 41% of cases
Knowledge-focused CompletedThis study tested whether an expensive PET scan called 18F-FDOPA helps doctors choose better treatments for people with high-grade gliomas, a type of aggressive brain tumor. About 110 patients whose cases were discussed by a team of experts were included. The main goal was to see…
Phase: NA • Sponsor: Centre Antoine Lacassagne • Aim: Knowledge-focused
Last updated May 26, 2026 09:06 UTC
-
Study reveals what breast cancer patients really think about exercise
Knowledge-focused CompletedThis study looked at 422 breast cancer patients to understand how their knowledge of exercise benefits, their current activity level, and their fatigue affect their beliefs about physical activity and their desire to be active. All participants were undergoing chemotherapy and we…
Phase: NA • Sponsor: Centre Antoine Lacassagne • Aim: Knowledge-focused
Last updated May 26, 2026 09:05 UTC
-
Scientists hunt for hidden chemical signs in breast tumors
Knowledge-focused CompletedThis study examined 52 breast cancer tumor samples and some blood samples to find chemical markers (metabolites) that might help understand different types of breast cancer better. The goal was to learn more about how cancer cells use energy and to find possible targets for futur…
Sponsor: Centre Antoine Lacassagne • Aim: Knowledge-focused
Last updated May 26, 2026 09:02 UTC
-
Can your genes predict breast cancer drug reactions?
Knowledge-focused CompletedThis study analyzed blood samples from 49 women with metastatic breast cancer to find genetic markers linked to how they respond to trastuzumab (Herceptin). The goal was to better understand side effects like heart toxicity and allergic reactions, as well as treatment effectivene…
Phase: NA • Sponsor: Centre Antoine Lacassagne • Aim: Knowledge-focused
Last updated May 26, 2026 09:01 UTC
-
Cancer Treatment's hidden toll: swallowing woes tracked for 18 months
Knowledge-focused CompletedThis study followed 240 adults with head and neck cancer for 18 months after their first treatment. Researchers used questionnaires and doctor evaluations to track how often and how severely swallowing problems occurred, and how long they lasted. The goal was to better understand…
Sponsor: Centre Antoine Lacassagne • Aim: Knowledge-focused
Last updated May 26, 2026 09:01 UTC
-
Cancer Patients' taste changes studied to fight malnutrition
Knowledge-focused CompletedThis study looked at how cancer treatment changes patients' sense of taste and smell, and how that affects their ability to follow a healthy Mediterranean diet. Researchers tracked 116 patients before and after 9 weeks of treatment. The goal is to understand these changes so bett…
Phase: NA • Sponsor: Centre Antoine Lacassagne • Aim: Knowledge-focused
Last updated May 26, 2026 09:01 UTC
-
Gene test may predict who gets severe chemo side effects
Knowledge-focused CompletedThis study looked at whether a genetic deficiency (DPD deficiency) can predict severe side effects from the chemotherapy drug capecitabine in women with metastatic breast cancer. Researchers analyzed blood samples from 303 participants to see if those with the deficiency experien…
Phase: NA • Sponsor: Centre Antoine Lacassagne • Aim: Knowledge-focused
Last updated May 26, 2026 08:58 UTC
-
Study tracks quality of life in elderly cancer patients to improve care
Knowledge-focused CompletedThis study followed 76 adults over age 70 with solid tumors who were starting chemotherapy for the first time. Researchers used questionnaires to measure quality of life, daily activities, and mental function. The goal was to learn how to better tailor cancer treatment and suppor…
Phase: NA • Sponsor: Centre Antoine Lacassagne • Aim: Knowledge-focused
Last updated May 26, 2026 08:56 UTC
-
New oxygen method may keep cancer patients safer during throat exams
Knowledge-focused CompletedThis study looked at 160 people with head and neck cancer who needed a scope exam of their throat. Researchers compared standard oxygen therapy with a high-flow system that delivers warm, moist oxygen at high rates. The goal was to see which method better prevents drops in oxygen…
Phase: NA • Sponsor: Centre Antoine Lacassagne • Aim: Knowledge-focused
Last updated May 26, 2026 08:54 UTC
-
Iron deficiency in cancer patients: a hidden problem?
Knowledge-focused CompletedThis study looked at how common iron deficiency is in 480 cancer patients starting chemotherapy. The goal was to find out how many patients might benefit from iron injections. Researchers measured iron levels using blood tests to better understand and manage anemia in cancer care…
Phase: NA • Sponsor: Centre Antoine Lacassagne • Aim: Knowledge-focused
Last updated May 26, 2026 08:35 UTC
-
Cancer patients face higher clot risk: new study investigates
Knowledge-focused CompletedThis study looked at 700 cancer patients to understand how often they develop dangerous blood clots (like deep vein thrombosis or pulmonary embolism). It focused on patients who already take blood thinners or have low platelet counts, which can complicate treatment. The goal was …
Phase: NA • Sponsor: Centre Antoine Lacassagne • Aim: Knowledge-focused
Last updated May 19, 2026 11:47 UTC
-
Hidden COVID-19 infections in cancer patients revealed by rapid testing
Knowledge-focused CompletedThis study aimed to find out how many cancer patients had been infected with COVID-19, including those without symptoms. Researchers used a rapid blood test to check for antibodies in 214 adults receiving cancer treatment. The goal was to better understand infection risks and hel…
Phase: NA • Sponsor: Centre Antoine Lacassagne • Aim: Knowledge-focused
Last updated May 19, 2026 11:47 UTC
-
Radiotherapy chat eases cancer patient worries, study finds
Knowledge-focused CompletedThis study looked at whether having an extra talk with a radiotherapy technician helps cancer patients get better information about their treatment. Over 300 adults with various cancers took part. The goal was to see if this extra chat reduces anxiety and helps patients feel more…
Phase: NA • Sponsor: Centre Antoine Lacassagne • Aim: Knowledge-focused
Last updated May 11, 2026 20:41 UTC